Disease Markers / 2015 / Article / Tab 1

Research Article

Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study

Table 1

Multivariate analysis of BST2 tissue expression levels and clinicopathologic factors of 132 CRC patients.

VariableHR95% CI value

Gender
 Male1
 Female0.700.42~1.170.17
Age (years)
 <651
 ≧651.911.18~3.11<0.01
TNM stage
 Early (I~II)1
 Late (III~IV)3.291.94~5.58<0.01
Differentiation
 Well1
 Moderate1.250.66~2.360.01
 Poor1.770.55~5.69
Histological type
 Adenocarcinoma1
 Mucinous carcinoma1.820.65~5.140.25
Chemotherapy
 Yes1
 No1.400.80~2.460.23
CEA (ng/mL)
 <5 1
 ≧52.021.21~3.37<0.01
BST2 (IHC score)
 Low (0–149)1
 High (150–300)1.640.98~2.740.05

HR: hazard ratio.
CI: confidence interval.